Sarbanes-Oxley Costs Affect Smaller Companies the Most

Pomeroy, Ann
August 2006
HR Magazine;Aug2006, Vol. 51 Issue 8, p14
The article presents the results of a study on the impact of Sarbanes-Oxley Act on companies in the U.S., conducted by law firm Foley & Lardner. Large companies paid more than $1 billion to become public in 2002. It found that before Sarbanes-Oxley was implemented, smaller companies paid an average of $1 million to be public. It presents an assessment of smaller firms before and after Sarbanes-Oxley.


Related Articles

  • By the numbers.  // njbiz;10/6/2014, Vol. 27 Issue 40, p1 

    The article presents the number of initial public offerings (IPO) through three quarters of 2014 in New Jersey.

  • DPOFilings May Have Reached Bottom SB-2 Continue to Gain in Popularity.  // SCOR Report;Mar2002, Vol. 9 Issue 3, p1 

    Focuses on the decrease in the filing of direct public offerings of businesses in the U.S. as of March 2002. Popularity of the small business (SB)-2 for small business; Restrictions issued by the U.S. Securities and Exchange Commission and the National Association of Securities Dealers.

  • Who needs underwriters? Anand, Anita I.; Johnson, Lewis D. // Canadian Investment Review;Spring2004, Vol. 17 Issue 1, p45 

    Discusses the use of direct public offerings (DPO) and underwriters by business enterprises in Canada and the U.S. Efficiency of a DPO; Use of the Internet to complete securities offerings; Suggestions for replacing the verification function of an underwriter.

  • NEW STOCK ISSUES GO UP, UP, UP, AND WALL STREET CRIES: MORE! Norton, Rob // Fortune;10/18/1993, Vol. 128 Issue 9, p27 

    Focuses on the boom in the initial public offerings (IPOs) market in the U.S., as of October 18, 1993. Number of companies that have already registered $6 billion in IPOs with the Securities and Exchange Commission to be issued next year; Reason for market's strength; Diversity of companies...

  • Targanta Seeks $86M In IPO For Antibiotic Development. Morrison, Trista // BioWorld Today;5/15/2007, Vol. 18 Issue 94, p1 

    The article reports on the planned initial public offering (IPO) of Cambridge, Massachusetts-based Targanta Therapeutics Corp. As the biotechnology firm prepares to file a new drug application for its antibiotic oritavancin in the first quarter of 2008, it has filed to raise $86.25 million in an...

  • Financings Roundup.  // BioWorld Today;10/10/2007, Vol. 18 Issue 197, p6 

    The article reports on the plan by Genoptix Inc. of Carlsbad, California to launch an initial public offering (IPO). The company has set a price range of $14 to $16 per share for its proposed IPO, which will include 5 million shares and an additional 750,000 shares to cover any overallotments....

  • Financings Roundup.  // BioWorld Today;10/10/2007, Vol. 18 Issue 197, p6 

    The article reports on the initial public offering (IPO) launched by MAP Pharmaceuticals Inc. of Mountain View, California. The company announced that its underwriters fully exercised their overallotment option by purchasing an additional 750,000 shares of common stock at $12 per share. The...

  • CenterPlate at Center Stage.  // Food Management;Jan2004, Vol. 39 Issue 1, p12 

    Reports on the initial public offering of Volume Services America Inc. on the American Stock Exchange in the U.S. Experimentation of an investment vehicle; Characterization of the investment vehicle; Difference between the Canadian and the American version of the investment vehicle.

  • Jamdat IPO hailed as harbinger. Gibbs, Colin // RCR Wireless News;10/4/2004, Vol. 23 Issue 40, p1 

    Reports on the outcomes of the initial public offering (IPO) launched by Jamdat Mobile Inc., a mobile-game developer based in the U.S. Total amount generated by the company from the IPO; Earnings of the company in the first six months of 2004; Implications of the succesful IPO launched by the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics